Prior episode of anoxia attenuates vasorelaxation in response to subsequent episode of anoxia

Am J Physiol. 1994 Mar;266(3 Pt 2):H974-9. doi: 10.1152/ajpheart.1994.266.3.H974.

Abstract

To examine the effect of a prior episode of anoxia on subsequent anoxia-mediated vasorelaxation, norepinephrine-precontracted endothelium-intact rat aortic rings were first exposed to anoxia (95% N2-5% CO2 for 5, 15, or 30 min) then to normoxia (95% O2-5% CO2 for 15 min). These rings were exposed again to anoxia for 30 min. First exposure of rings to anoxia for 30 min resulted in 77 +/- 4% decrease in tone (vasorelaxation), whereas second exposure resulted in only 10 +/- 4% relaxation (n = 11, P < 0.001 vs. relaxation during first exposure). First exposure of rings to anoxia for 5 or 15 min also diminished relaxation to 59 +/- 3 and 19 +/- 8%, respectively, on second exposure to anoxia (both P < 0.01 vs. relaxation during 1st anoxia). Attenuation of vasorelaxation by prior episode of anoxia was not affected by treatment of rings with indomethacin (10(-5) M), the Ca2+ channel blocker felodipine (10(-6) M), the superoxide anion scavenger superoxide dismutase (100 micrograms/ml), or adenosine A1 and A2 blockers (each 10(-6) M). To examine the role of intact functional endothelium in attenuation of vasorelaxation during second anoxic exposure, rings were deendothelialized and treated with the nitric oxide synthase inhibitor NG-monomethyl-L-arginine (L-NMMA; 10(-4) M) or the guanylate cyclase inhibitor methylene blue (MB; 2 x 10(-5) M). In all deendothelialized rings, vasorelaxation during second anoxic exposure was similar to that during first anoxic exposure (100 +/- 0 vs. 98 +/- 3%, P = NS).(ABSTRACT TRUNCATED AT 250 WORDS)

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenosine / physiology
  • Animals
  • Aorta / drug effects
  • Aorta / physiopathology
  • Arginine / analogs & derivatives
  • Arginine / pharmacology
  • Calcium / metabolism
  • Endothelium, Vascular / physiopathology
  • Free Radicals
  • Hypoxia / physiopathology*
  • In Vitro Techniques
  • Nitric Oxide / antagonists & inhibitors
  • Prostaglandin-Endoperoxide Synthases / metabolism
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Recurrence
  • Vasodilation*
  • omega-N-Methylarginine

Substances

  • Free Radicals
  • Purinergic P1 Receptor Antagonists
  • omega-N-Methylarginine
  • Nitric Oxide
  • Arginine
  • Prostaglandin-Endoperoxide Synthases
  • Adenosine
  • Calcium